Glaucoma is one of the leading causes of blindness worldwide. The main characteristic features include optic disc cupping, visual field loss, and in most instances a raised intraocular pressure. Primary open angle glaucoma accounts for nearly two thirds of all cases, while angle closure glaucoma contributes the majority of the remainder. Screening for glaucoma is not cost-effective, and diagnosis of the primary open angle type is usually an incidental finding during ophthalmological examination. Various treatment options, including medical and surgical interventions are accessible in the management of glaucoma. This article contains a brief description on the pathophysiology and focuses on the pharmacological options available in the t...
Glaucoma is the first cause of unemendable visual disability and blindness worldwide [1]. If glaucom...
Glaucoma is a heterogeneous group of diseases with an intraocular pressure (IOP) higher than the pre...
Glaucoma has been highlighted as a priority eye disease by the World Health Organization’s global in...
Glaucoma is one of the leading causes of blindness worldwide. The main characteristic features inclu...
Glaucoma is a silent condition very rarely presenting with headaches and only leading to decreased v...
Background: In the United States, glaucoma is the second most prevalent cause of official blindness....
Background: In the United States, glaucoma is the second most prevalent cause of official blindness....
Background: In the United States, glaucoma is the second most prevalent cause of official blindness....
The purpose of this review is to discuss the topics relevant to the use of intraocular pressure-lowe...
Glaucoma is one of the most serious and common disease of the eye pathology that doctors and nursing...
AbstractGlaucoma is the most common optic neuropathy characterized by normal to raised intraocular p...
Glaucoma is the most common form of irreversible blindness in the world, and second only to cat...
Glaucoma affecting 60 million people all over the world and it will be 80 million till 2020. There a...
Glaucoma is the leading cause of blindness throughout the world (after cataracts); therefore, genera...
The rate of progression is the deciding factor in when and how to treat primary open-angle glaucoma....
Glaucoma is the first cause of unemendable visual disability and blindness worldwide [1]. If glaucom...
Glaucoma is a heterogeneous group of diseases with an intraocular pressure (IOP) higher than the pre...
Glaucoma has been highlighted as a priority eye disease by the World Health Organization’s global in...
Glaucoma is one of the leading causes of blindness worldwide. The main characteristic features inclu...
Glaucoma is a silent condition very rarely presenting with headaches and only leading to decreased v...
Background: In the United States, glaucoma is the second most prevalent cause of official blindness....
Background: In the United States, glaucoma is the second most prevalent cause of official blindness....
Background: In the United States, glaucoma is the second most prevalent cause of official blindness....
The purpose of this review is to discuss the topics relevant to the use of intraocular pressure-lowe...
Glaucoma is one of the most serious and common disease of the eye pathology that doctors and nursing...
AbstractGlaucoma is the most common optic neuropathy characterized by normal to raised intraocular p...
Glaucoma is the most common form of irreversible blindness in the world, and second only to cat...
Glaucoma affecting 60 million people all over the world and it will be 80 million till 2020. There a...
Glaucoma is the leading cause of blindness throughout the world (after cataracts); therefore, genera...
The rate of progression is the deciding factor in when and how to treat primary open-angle glaucoma....
Glaucoma is the first cause of unemendable visual disability and blindness worldwide [1]. If glaucom...
Glaucoma is a heterogeneous group of diseases with an intraocular pressure (IOP) higher than the pre...
Glaucoma has been highlighted as a priority eye disease by the World Health Organization’s global in...